Search

everythinglearnresearchcommunity

for

Search:↓

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

β-Catenin signaling is involved in brain cell growth after injury and could be a therapy target.

Toll-like receptors are important for wound healing, but can slow it down in diabetic wounds.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

A blood pressure drug, diltiazem, may also help treat influenza.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Cell aging can be both good and bad for tissue repair.

Genetic variants linked to ten skin diseases were found, showing both immune and non-immune factors play a role.

Genetic research has advanced our understanding of skin diseases, but complex conditions require an integrative approach for deeper insight.

Fine wool sheep have more genes for wool quality, while coarse wool sheep have more for skin and muscle traits.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Stopping adalimumab and starting methotrexate with topical treatments improved the woman's scalp psoriasis and hair regrew.

SLE is rare in Uganda but often has complications and overlaps with rheumatoid arthritis.

The document concludes that better understanding the wound microbiome can improve chronic wound care by preserving helpful bacteria and targeting harmful ones.

Key genes linked to hair growth and cancer were identified in hairless mice.

The document explains the difficulty in diagnosing and treating brain diseases caused by the immune system and stresses the need for quick and accurate tests.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Topical treatments can deliver active molecules to skin stem cells, potentially helping treat skin and hair disorders, including skin cancers and hair loss.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

Early diagnosis and aggressive treatment are crucial for Cicatricial Alopecia, and treatment effectiveness varies among patients.

2011 dermatological research found new skin aging markers, hair loss causes, skin defense mechanisms, and potential for new treatments.

People with Down syndrome have higher rates of certain immune-related conditions and need special medical attention.

Higher EULAR/ACR scores in SLE patients predict more organ damage.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.